Top Markets
#1 Islamic Coin Islamic Coin +151.54%
#2 Akedo Akedo +66.39%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.78%
#5 Velvet Velvet +41.51%
#6 Cross Cross +35.02%
#7 Black Phoenix Black Phoenix +34.13%
#8 Cap Cap +20.45%
#9 DoubleZero DoubleZero +15.18%
#10 GRVT Token GRVT Token +9.99%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
CaliPharms, Inc. CaliPharms, Inc.

CaliPharms, Inc.

KGET
Rank in Stocks #39482
CaliPharms, Inc. is an entity actively engaged in the medicinal cannabis... CaliPharms, Inc. is an entity actively engaged in the medicinal cannabis industry across the United States. The company's primary focus lies within the THC and CBD-infused beverage sector. It rebranded to CaliPharms, Inc. in January 2017, having previously operated under the name Kleangas Energy Technologies, Inc. The corporate headquarters for CaliPharms, Inc. are located in Temecula, California.
Share Price
$0.00004
Last synced: 2026-08-12
Market Cap
$474.35K
Change (1 day)
0.00%
Change (1 year)
3,900.00%
Country
US
Trade CaliPharms, Inc. (KGET)

Category

Healthcare
P/S ratio for CaliPharms, Inc. (KGET)
P/S ratio as of 2026 TTM: 0
According to CaliPharms, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for CaliPharms, Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
8.17 -
IN